Click here to download PDF Version of the final programme (1.8 MB)

Search through the abstracts in detail! Click here to start!

Click here to see photos from the conference!

HINT: to download photos from the album, look for the download icon in the bottom right corner

2011-1

About the Agenda Builder

The agenda builder is a simple, light-weight tool to manage your schedule. There are filters to narrow your search by day, track and/or presenter.

  • To use, simply click the "Add to my agenda" link. The  selected item will remain in memory indefinitely. 
  • Limitation: It will only "remember" the computer employed AND as long as you do not erase your "cookies".

>> Day 1 - Saturday, July 3, 2010

Print PDF

July 2, 2010
5:00 PM -
9:00 PM
Registration

July 3, 2010 – Day 1
7:00 AM
Registration


Session 1: Natural history and screening concept

8:35 AM
Welcome & Opening Remarks
Xavier Bosch, MD, PhD
Director, Research Program of Cancer Epidemiology, Catalan Oncology Institute (ICO)

8:45 AM
The burden of high risk HPV
Xavier Bosch, MD, PhD
Director, Research Program of Cancer Epidemiology, Catalan Oncology Institute (ICO)
9:00 AM
HPV: natural history of the infection from a biological perspective

Doorbar_JohnJohn Doorbar, PhD
Group Leader, Division of Virology, National Institute for Medical Research, London, UK
9:15 AM
HPV: natural history of the infection from an epidemiological and clinical perspective
0084_webMark Schiffman, MD, MPH
Senior Investigator, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, USA
9:30 AM
HPV: natural history of the infection in younger women
0068_webAnna-Barbara Moscicki, MD
Professor of Pediatrics, Director for Clinical Services, University of California, San Francisco, USA
9:45 AM
Questions & Answers
10:00 AM
Break
10:30 AM
Cervical cancer screening; the principles and evaluation parameters of the programme
10:45 AM
Cytology-based cervical cancer screening
Ahti Anttila, PhD
Finnish Cancer Registry, Helsinki, Finland
11:00 AM
Biological markers in cervical cancer screening
Chris J.L.M. Meijer
Department of Pathology, Free University Hospital, Amsterdam, The Netherlands
11:15 AM
Questions & Answers
11:30
Lunch


Session 2: The comprehensive value of HPV tests in prevention and management

12:45 PM
Testing for HPV. Requirements for clinical use and usefulness of HPV typing in the clinical practice
0114_webFrançois Coutlée
Professor, Microbiology and Immunology, Université de Montréal, Montreal, Canada

1:00 PM
HPV testing for primary screening
Marie-Hélène Mayrand, MD
Départements de Gynécologie et de Médecine Sociale et Préventive, Université de Montréal et CHUM

1:15 PM
HPV testing for the triage of ASCUS and LSIL; principles and results
Castle_Philip_150x175Philip E. Castle, PhD, MPH
Investigator National Cancer Institute, National Institutes of Health

1:30 PM
HPV tests in the post-treatment follow up

1:45 PM
Follow up and counseling for HPV+ women with normal smears

2:00 PM
Cervical screening in populations vaccinated against HPV

2:15 PM
Questions & Answers
2:30 PM
Break

3:00 PM
Follow up, counseling and treatment issues in pre neoplastic cervical diseases
0018_webJ. Thomas Cox, MD
Director of Women’s Health, University of California, Santa Barbara, USA

3:15 PM
Multifocal HPV disease and implication for long term follow-up

3:30 PM
Rational transition from research studies to implementation in programmes

Cuzick_Jack_150x175Jack Cuzick, PhD
John Snow Professor of Epidemiology, Head of Department. Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Queen Mary, University of London, Wolfson Institute of Preventive Medicine

3:45 PM
Sustainable screening for developing countries
0046_webJose A. Jeronimo, MD
Director START-UP Project, Reproductive Health, PATH, Seattle, USA

4:00 PM
Questions & Answers

4:15 PM
Closing comments
Castle_Philip_150x175Philip E. Castle, PhD, MPH
Investigator National Cancer Institute, National Institutes of Health

Innovator_V2